INCLUSION BODY MYOSITIS
Clinical trials for INCLUSION BODY MYOSITIS explained in plain language.
Never miss a new study
Get alerted when new INCLUSION BODY MYOSITIS trials appear
Sign up with your email to follow new studies for INCLUSION BODY MYOSITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First test of Fat-Derived stem cells for debilitating muscle disease
Disease control CompletedThis small, early-stage study tested whether stem cells taken from a patient's own fat tissue could be safely injected into the muscles of people with Inclusion Body Myositis (IBM). IBM is a progressive disease that causes severe muscle weakness, especially in the thighs and hand…
Matched conditions: INCLUSION BODY MYOSITIS
Phase: NA • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New drug tested to slow Muscle-Wasting disease
Disease control CompletedThis study tested an investigational drug called ABC008 for adults with inclusion body myositis, a rare muscle-wasting disease. It aimed to see if the drug could safely slow the decline in muscle strength and function compared to a placebo. The trial involved 272 participants and…
Matched conditions: INCLUSION BODY MYOSITIS
Phase: PHASE2, PHASE3 • Sponsor: Abcuro, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Military mystery: What's causing Soldiers' muscle disease?
Knowledge-focused CompletedThis study aimed to understand why some military personnel develop myositis, a rare autoimmune disease that attacks muscles, while others do not. Researchers compared service members with myositis to healthy service members, looking for common environmental exposures during milit…
Matched conditions: INCLUSION BODY MYOSITIS
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC